ChemSpider 2D Image | AT9283 | C19H23N7O2

AT9283

  • Molecular FormulaC19H23N7O2
  • Average mass381.432 Da
  • Monoisotopic mass381.191315 Da
  • ChemSpider ID21437042

More details:

Validated by Experts, Validated by Users, Non-Validated, Removed by Users

1-Cyclopropyl-3-{3-[5-(4-morpholinylmethyl)-1H-benzimidazol-2-yl]-1H-pyrazol-4-yl}harnstoff [German] [ACD/IUPAC Name]
1-Cyclopropyl-3-{3-[5-(4-morpholinylmethyl)-1H-benzimidazol-2-yl]-1H-pyrazol-4-yl}urea [ACD/IUPAC Name]
1-Cyclopropyl-3-{3-[5-(4-morpholinylméthyl)-1H-benzimidazol-2-yl]-1H-pyrazol-4-yl}urée [French] [ACD/IUPAC Name]
1-Cyclopropyl-3-{3-[5-(morpholin-4-ylmethyl)-1H-benzimidazol-2-yl]-1H-pyrazol-4-yl}harnstoff
1-cyclopropyl-3-{3-[5-(morpholin-4-ylmethyl)-1H-benzimidazol-2-yl]-1H-pyrazol-4-yl}urea
896466-04-9 [RN]
AT9283
AT-9283
Urea, N-cyclopropyl-N'-[3-[5-(4-morpholinylmethyl)-1H-benzimidazol-2-yl]-1H-pyrazol-4-yl]- [ACD/Index Name]
XAV9KYN9WL
More...

Validated by Experts, Validated by Users, Non-Validated, Removed by Users

CCRIS 4693 [DBID]
  • Experimental Physico-chemical Properties
  • Miscellaneous

    • Bio Activity:

      AT9283 is a multi-targeted inhibitor with IC50s of 4, 1.2, 1.1 and approximate 3 nM for Bcr-Abl(T3151), JAK2 and JAK3, Aurora A and Aurora B, respectively. MedChem Express
      AT9283 is a multi-targeted inhibitor with IC50s of 4, 1.2, 1.1 and approximate 3 nM for Bcr-Abl(T3151), JAK2 and JAK3, Aurora A and Aurora B, respectively.; IC50 Value: 1.2 nM(Jak2); 1.1 nM(Jak3); Target: Aurora A/B; JAK2/3; in vitro: AT9283 leads to a clear polyploid phenotype by inhibiting the activity of Aurora B kinase in HCT116 cells with IC50 of 30 nM. MedChem Express HY-50514
      AT9283 is a multi-targeted inhibitor with IC50s of 4, 1.2, 1.1 and approximate 3 nM for Bcr-Abl(T3151), JAK2 and JAK3, Aurora A and Aurora B, respectively.;IC50 Value: 1.2 nM(Jak2); 1.1 nM(Jak3);Target: Aurora A/B; JAK2/3;In vitro: AT9283 leads to a clear polyploid phenotype by inhibiting the activity of Aurora B kinase in HCT116 cells with IC50 of 30 nM. Furthermore, AT9283 also produces the potent inhibition on HCT116 colony formation.;In vivo: In HCT116 human colon carcinoma xenograft bearing mice, AT9283 treatment (15 mg/kg and 20 mg/kg) for 16 days results in a significant tumor growth inhibition of 67% and 76%, respectively. In addition, AT9283 also exhibits a significantly longer half-life in tumors(2.5 hours) compared with plasma (0.5 hour) and modest oral bioavailability in mice (Fp.o. = 24%). MedChem Express HY-50514
      Aurora Kinase MedChem Express HY-50514
      Aurora Kinase JAK MedChem Express HY-50514
      Cell Cycle/DNA Damage MedChem Express HY-50514
      Cell Cycle/DNA Damage; JAK/STAT Signaling; MedChem Express HY-50514

Predicted data is generated using the ACD/Labs Percepta Platform - PhysChem Module, version: 14.00

Density: 1.5±0.1 g/cm3
Boiling Point:
Vapour Pressure:
Enthalpy of Vaporization:
Flash Point:
Index of Refraction: 1.715
Molar Refractivity: 103.1±0.4 cm3
#H bond acceptors: 9
#H bond donors: 4
#Freely Rotating Bonds: 5
#Rule of 5 Violations: 0
ACD/LogP: 0.92
ACD/LogD (pH 5.5): 0.22
ACD/BCF (pH 5.5): 1.00
ACD/KOC (pH 5.5): 14.42
ACD/LogD (pH 7.4): 0.93
ACD/BCF (pH 7.4): 2.93
ACD/KOC (pH 7.4): 73.96
Polar Surface Area: 111 Å2
Polarizability: 40.9±0.5 10-24cm3
Surface Tension: 86.5±5.0 dyne/cm
Molar Volume: 262.5±5.0 cm3

Click to predict properties on the Chemicalize site


Advertisement